LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus
03 Jul 2024 //
PR NEWSWIRE
Lotte Biologics and Merck Sign Letter of Intent (LOI) for Strategic Partnership
31 May 2024 //
PRESS RELEASE
LOTTE BIOLOGICS Made a Notable Mark at the CPhI Japan 2024 Conference
18 Apr 2024 //
PRESS RELEASE
LOTTE BIOLOGICS has been honored at the 2024 KSBB Spring Meeting
18 Apr 2024 //
PRESS RELEASE
The Regulatory Innovation Meeting for Support of Biopharmaceutical CDMOs
29 Mar 2024 //
PRESS RELEASE
LOTTE BIOLOGICS Signs an Agreement with Syracuse University
27 Mar 2024 //
PRESS RELEASE
LOTTE BIOLOGICS Participates in `2024 DCAT Week`, Exploring Global Business
22 Mar 2024 //
PRESS RELEASE
LOTTE BIOLOGICS Reveals Triple Digit Hiring Plan for 2024
04 Mar 2024 //
PRESS RELEASE
LOTTE BIOLOGICS awarded Grand Prize at 6th Republic of Korea Job Creation Awards
23 Feb 2024 //
PRESS RELEASE
LOTTE BIOLOGICS Signs Strategic Business Agreement with NJ Bio
22 Jan 2024 //
PRESS RELEASE
LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Conference
09 Jan 2024 //
PR NEWSWIRE
CDMO Lotte plans major real estate move in its native Korea
06 Oct 2023 //
FIERCE PHARMA
Korean firm Lotte Biologics internalises Antibody-Drug Conjugate services
11 Jul 2023 //
BIOSPECTRUM ASIA
Lotte Biologics Signs a 4-party MOU with LOTTE Corporation
20 Jun 2023 //
PRESS RELEASE
Lotte Biologics to Kick off their CDMO Business Campaign at Convention 2023’
08 Jun 2023 //
PRESS RELEASE
Lotte Biologics Holds First Anniversary Commemorative Event
02 Jun 2023 //
PRESS RELEASE
Lotte Bio Kicks Off Industry–Academia Collaboration with Syracuse University
26 May 2023 //
PRESS RELEASE
Lotte Biologics at `Invest Fair` of BIO KOREA 2023
12 May 2023 //
PRESS RELEASE
Lotte Biologics USA Conducts Environmental Clean up Volunteer Activities
28 Apr 2023 //
PRESS RELEASE
Lotte Biologics USA Signs LOI with Merck MilliporeSigma
26 Apr 2023 //
PRESS RELEASE
Lotte Bio Announces Investment in PINOT BIO, ADC Platform Development Pioneer
21 Apr 2023 //
PRESS RELEASE
Lotte Held a Ceremony to Commemorate the Acquisition of Syracuse Plant
18 Apr 2023 //
PRESS RELEASE
Plans for Growth and Success of LOTTE BIOLOGICS
11 Apr 2023 //
PRESS RELEASE
Lotte Biologics and EXCELLGENE Announce Collaboration to Enhance CDO Business
03 Apr 2023 //
PRESS RELEASE
Lotte Biologics Receives Low-Cost Electricity from NY State to Reduce Costs
29 Mar 2023 //
PRESS RELEASE
LOTTE Biologics Unveils CDMO Strategy
09 Feb 2023 //
CONTRACT PHARMA
Lotte Biologics announces $3 B investment plan to leap forward as global CDMO
24 Jan 2023 //
BIOPROCESSINTL
Lotte Announces Blueprint to Leap Forward as a Global CDMO
17 Jan 2023 //
PRESS RELEASE
Lotte Completes Acquisition of Biologics Manufacturing Plant in Syracuse, NY
03 Jan 2023 //
PRESS RELEASE